Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership

Got story updates? Submit your updates here. ›

Kane Biotech Inc., a company transforming wound care with FDA-cleared and Health Canada-approved products, has announced two significant expansions to its U.S. commercialization strategy. This includes signing a distribution partnership with Marathon Medical Corporation, a federally verified Service-Disabled Veteran-Owned Small Business, to support entry into the U.S. Veterans Affairs, Department of Defense, and Indian Health Services markets. Kane has also commenced building a contract-based sales team with representatives across the U.S. to increase brand presence, enhance customer engagement, and accelerate access to its revyve wound care line.

Why it matters

This partnership with Marathon Medical and the expansion of Kane's sales team are crucial steps in the company's strategy to establish a scalable, multi-channel U.S. distribution infrastructure for its innovative wound care solutions. By gaining access to established U.S. government-authorized purchasing pathways and building a robust national sales foundation, Kane aims to make its revyve products more easily accessible to veterans, active service members, indigenous peoples, and their healthcare providers.

The details

Through the distribution agreement with Marathon Medical, Kane Biotech gains access to established U.S. government-authorized purchasing pathways, significantly streamlining procurement, logistics, and product onboarding for the revyve wound care line. Marathon's national distribution capabilities, decades of experience serving federal healthcare agencies, and veteran-owned status help reduce market entry barriers and strengthen Kane's ability to penetrate and scale within the U.S. healthcare system. Additionally, Kane has commenced building a contract-based sales team with representatives across the U.S. to increase brand presence, enhance customer engagement, and accelerate access to the revyve product line for clinicians nationwide.

• The distribution agreement with Marathon Medical was signed in March 2026.
• Kane Biotech has commenced building its contract-based sales team in 2026 and will continue to expand this group throughout the year.

What they’re saying

What’s next

Kane Biotech will continue to build its contract-based sales team throughout 2026 to further expand its national sales foundation and increase access to the revyve wound care line for clinicians across the country.